Inventor profile of:

Johan Auwerx

City:

Buchillon

Country:

Switzerland

Published Applications:

35

Last publication date:

2025-12-11

Top Assignees for applications by Johan Auwerx

The entities that hold a legal rights for patent applications filed by inventor Auwerx Johan:

Recent patent applications by Auwerx Johan

Johan Auwerx from Buchillon, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-12-11
US20250375415A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#2 | 2025-07-17
US20250228817A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#3 | 2025-07-17
US20250228816A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#4 | 2024-10-10
US20240335505A1
Human necessities

PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS

#5 | 2024-09-12
US20240299420A1
Human necessities

TETRACYCLINE DERIVATIVE-INDUCED MITOHORMESIS MEDIATES DISEASE TOLERANCE AGAINST VIRAL INFECTIONS

#6 | 2024-05-16
US20240156777A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION AND TREATING NEURODEGENERATIVE DISEASES AND COGNITIVE DISORDERS

#7 | 2024-03-28
US20240100016A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#8 | 2023-12-07
US20230390238A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#9 | 2023-07-27
US20230233523A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#10 | 2022-09-15
US20220288004A1
Human necessities

TREATMENT AND PREVENTION OF AGING RELATED-DISEASE AND/OR AGING BY THE INHIBITION OF SPHINGOLIPIDS

#11 | 2022-09-08
US20220280475A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#12 | 2022-04-14
US20220110902A1
Human necessities

Methods of treating amyloid-beta peptide diseases

#13 | 2021-11-18
US20210353591A1
Human necessities

Enhancing autophagy or increasing longevity by administration of urolithins

#14 | 2021-05-13
US20210137959A1
Human necessities

AGENTS AND METHODS USING THEREOF FOR THE PREVENTION AND TREATMENT OF STEM CELL MUSCLE DISORDERS

#15 | 2021-03-04
US20210059982A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#16 | 2020-12-24
US20200397748A1
Human necessities

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

#17 | 2020-07-02
US20200207721A1
Chemistry; metallurgy

Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase

#18 | 2020-03-26
US20200096524A1
Physics

PLASMA AND LIVER LIPID SPECIES AS BIOMARKERS OF FATTY LIVER

#19 | 2019-10-31
US20190328758A1
Human necessities

Methods of treating mitochondrial dysfunction

#20 | 2019-02-21
US20190054098A1
Human necessities

AGENTS AND METHODS USING THEREOF FOR THE PREVENTION AND TREATMENT OF STEM CELLS SENESCENCE

#21 | 2018-12-20
US20180360862A1
Human necessities

Agents and methods using thereof for the prevention and treatment of stem cell muscle disorders

#22 | 2018-10-25
US20180303794A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#23 | 2018-01-18
US20180015069A1
Human necessities

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS OR PRECURSORS THEREOF

#24 | 2017-09-07
US20170252362A1
Human necessities

METHODS & COMPOUNDS USEFUL IN HEMATOPOIETIC STEM CELL MEDICINE

#25 | 2017-06-29
US20170182076A1
Human necessities

METHODS OF TREATING MITOCHONDRIAL DYSFUNCTION

#26 | 2017-05-25
US20170143667A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#27 | 2017-05-25
US20170143666A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#28 | 2016-07-28
US20160213643A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#29 | 2016-07-28
US20160213641A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

#30 | 2016-01-07
US20160000753A1
Human necessities

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

#31 | 2014-07-03
US20140187611A1
Human necessities

Mitochondrial ribosomal proteins as aging regulators

#32 | 2014-05-29
US20140147434A1
Human necessities

NCoR1 is a Physiological Modulator of Muscle Mass and Oxidative Function

#33 | 2014-03-06
US20140065099A1
Human necessities

Methods of Treating Mitochondrial Dysfunction

#34 | 2014-01-16
US20140018415A1
Human necessities

Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof

#35 | 2012-06-28
US20120164243A1
Human necessities

Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders

InventorID:

615412 ⎘